Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review.

Abstract:

:Transcranial magnetic stimulation is an increasingly popular FDA-approved treatment for resistant depression, migraines, and OCD. Research is also underway for its use in various other psychiatric and medical disorders. Although rare, seizures are a potential adverse event of TMS treatment. In this article, we discuss TMS-related seizures with the various coils used to deliver TMS, the risk factors associated with seizures, the differential diagnosis of its presentations, the effects of sleep deprivation and alcohol use on seizures, as well as seizure risks with protocols for traditional TMS, theta-burst stimulation, and accelerated TMS. A discussion is presented comparing the potential risk of seizures with various psychotropic medications versus TMS. Included are case reports of TMS seizures in the child/adolescent patient, bipolar disorder patients, patients with a history of a traumatic brain injury, and those with epilepsy. Reports are also shared on TMS use without seizures in patients with a history of head injuries and TMS's continued use if patients have a seizure during their TMS treatment. Findings generated in this review suggest the following. Seizures, if present, are usually self-limiting. Most treatment recommendations for TMS-related seizures are supportive in nature. The risk of TMS-related seizures is <1% overall. TMS has successfully been used in patients with epilepsy, traumatic brain injuries, and those with a prior TMS-related seizure. The rate of TMS-related seizures is comparable to that of most psychotropic medications. While having a seizure is a rare but serious adverse effect of TMS, the benefits of treating refractory depression with TMS may outweigh the risk of suicidal ideation and other significant complications of depression.

authors

Stultz DJ,Osburn S,Burns T,Pawlowska-Wajswol S,Walton R

doi

10.2147/NDT.S276635

subject

Has Abstract

pub_date

2020-12-07 00:00:00

pages

2989-3000

eissn

1176-6328

issn

1178-2021

pii

276635

journal_volume

16

pub_type

杂志文章,评审
  • Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders.

    abstract::In the last two decades, a growing body of evidence has shown that lithium has several neuroprotective effects. Several neurobiological mechanisms have been proposed to underlie these clinical effects. Evidence from preclinical studies suggests that neuroprotection induced by lithium is mainly related to its potent in...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S33086

    authors: Diniz BS,Machado-Vieira R,Forlenza OV

    更新日期:2013-01-01 00:00:00

  • Lacosamide for the prevention of partial onset seizures in epileptic adults.

    abstract::Lacosamide is a newly registered antiepileptic drug with dual mechanisms of action. It selectively enhances slow inactivation of voltage-gated sodium channels, resulting in stabilization of hyperexcitable neuronal membranes and inhibition of repetitive neuronal firing. It also binds to a collapsing-response mediator p...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s7967

    authors: Kelemen A,Halász P

    更新日期:2010-09-07 00:00:00

  • Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson's Disease.

    abstract:Objective:Stem cell transplantation is a promising strategy with great potential to treat Parkinson's disease (PD). Nevertheless, improving the cell delivery route and optimising implanted cells are necessary to increase the therapeutic effect. Herein, we investigated whether intranasal delivery of bone marrow stromal ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S238646

    authors: Tang Y,Han L,Bai X,Liang X,Zhao J,Huang F,Wang J

    更新日期:2020-01-23 00:00:00

  • Profile of agomelatine and its potential in the treatment of generalized anxiety disorder.

    abstract:BACKGROUND:Although many generalized anxiety disorder (GAD) patients respond to the available pharmacological treatments, nearly half of them do not present the expected results. Besides, the side effects associated to some drugs have a negative impact on treatment adherence. Therefore, the aim of this review was to re...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S67470

    authors: Levitan MN,Papelbaum M,Nardi AE

    更新日期:2015-05-05 00:00:00

  • New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children.

    abstract::Treatment guidelines from the American Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics state that stimulant medications have the most evidence for safety and efficacy in the treatment of childhood attention deficit hyperactivity disorder (ADHD). Longer-acting stimulants are thus consi...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s3328

    authors: Domnitei D,Madaan V

    更新日期:2010-05-25 00:00:00

  • Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies.

    abstract::The essential features of bipolar affective disorder involve the cyclical occurrence of high (manic or hypomanic episodes) and low mood states. Depressive episodes in both bipolar I and II disorder are more numerous and last for longer duration than either manic or hypomanic episodes. In addition depressive episodes a...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s1636

    authors: Gajwani P,Muzina DJ,Kemp DE,Gao K,Calabrese JR

    更新日期:2007-12-01 00:00:00

  • Structured relaxation in the treatment of akathisia: case series.

    abstract:PURPOSE:Akathisia remains a common side effect especially from antipsychotic medication. If the condition is diagnosed the management options are limited. SUBJECTS/METHODOLOGY: We tested a structured relaxation program on nine patients with a diagnosis of schizophrenia suffering from akathisia. All patients were rated ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s9810

    authors: Hansen LK,L'allemand T,Thiry F,Baldwin DS

    更新日期:2010-05-25 00:00:00

  • Biomarkers for depression: recent insights, current challenges and future prospects.

    abstract::A plethora of research has implicated hundreds of putative biomarkers for depression, but has not yet fully elucidated their roles in depressive illness or established what is abnormal in which patients and how biologic information can be used to enhance diagnosis, treatment and prognosis. This lack of progress is par...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S114542

    authors: Strawbridge R,Young AH,Cleare AJ

    更新日期:2017-05-10 00:00:00

  • Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study.

    abstract:INTRODUCTION:Essential tremor (ET) is the most common movement disorder in the adult population. At present ET treatment shows limited efficacy, particularly in patients with severe and disabling symptoms. This study evaluates the clinical efficacy of mirtazapine in an untreated ET patient population. MATERIALS AND ME...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:

    authors: Uccellini D,Grampa G,La Spina I,Nasuelli D,Neromante I,Politini L,Reverberi F,Porazzi D,Carli V,Camardese G

    更新日期:2006-03-01 00:00:00

  • Anxiolytics may promote locomotor function recovery in spinal cord injury patients.

    abstract::Recent findings in animal models of paraplegia suggest that specific nonbenzodiazepine anxiolytics may temporarily restore locomotor functions after spinal cord injury (SCI). Experiments using in vitro models have revealed, indeed, that selective serotonin receptor (5-HTR) ligands such as 5-HTR(1A) agonists, known as ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s2839

    authors: Guertin PA

    更新日期:2008-08-01 00:00:00

  • Patients' health literacy in psychotic disorders.

    abstract::Compliance and relapse are major issues in the treatment of psychotic disorders. About 50% of subjects with schizophrenia do not comply with treatment and relapse rates of 65% are reported after one year and 80% after two years. Drug treatments are effective against psychotic symptoms, but cannot promote functional re...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:

    authors: Saba G,Mékaoui L,Leboyer M,Schürhoff F

    更新日期:2007-08-01 00:00:00

  • Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients.

    abstract:BACKGROUND:This study aimed to evaluate synthetic cannabinoid (SC)-induced psychosis in terms of patient profile and clinical characteristics with reference to concurrently hospitalized schizophrenic patients. METHODS:A total of 81 male patients diagnosed with psychotic disorder induced by the use of SCs (n=50; mean (...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S107622

    authors: Altintas M,Inanc L,Oruc GA,Arpacioglu S,Gulec H

    更新日期:2016-08-02 00:00:00

  • Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia.

    abstract:INTRODUCTION:Telomere shortening is strongly associated with higher mortality rates and has been shown in a number of age-related diseases, such as cardiovascular disorders, diabetes mellitus, Alzheimer's disease, and psychiatric disorders. Oxidative stress is known to induce DNA breaks and genome instability. Telomeri...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S82468

    authors: Pawelczyk T,Szymanska B,Grancow-Grabka M,Kotlicka-Antczak M,Pawelczyk A

    更新日期:2015-06-22 00:00:00

  • Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study.

    abstract:Purpose:Whole-exome sequencing (WES) of multiplex families is a promising strategy for identifying causative variations for common diseases. To identify rare recessive risk variations for schizophrenia, we performed a WES study in a consanguineous family with affected siblings. We then performed follow-up sequencing of...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S218773

    authors: Igeta H,Watanabe Y,Morikawa R,Ikeda M,Otsuka I,Hoya S,Koizumi M,Egawa J,Hishimoto A,Iwata N,Someya T

    更新日期:2019-08-19 00:00:00

  • Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia.

    abstract:BACKGROUND:Metabolic syndrome (MetS) is one of the primary reasons for increased mortality in patients with schizophrenia. The mechanisms involved in its pathogenesis are not well understood. OBJECTIVE:To estimate the prevalence of MetS in adult outpatients with schizophrenia according to the presence or absence of ne...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S75449

    authors: Sicras-Mainar A,Maurino J,Ruiz-Beato E,Navarro-Artieda R

    更新日期:2014-12-30 00:00:00

  • Delirium as a complication of the surgical intensive care.

    abstract:BACKGROUND:The aim of this study was to examine the impact of somatic illnesses, electrolyte imbalance, red blood cell count, hypotension, and antipsychotic and opioid treatment on the duration of delirium in Central Intensive Care Unit for Surgery. PATIENTS AND METHODS:Patients who were admitted to the Department of ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S115800

    authors: Horacek R,Krnacova B,Prasko J,Latalova K

    更新日期:2016-09-22 00:00:00

  • Risperidone for children and adolescents with autism spectrum disorder: a systematic review.

    abstract:Background:Various clinical trials suggested that risperidone was beneficial in the treatment of autism spectrum disorder (ASD) in children and adolescents. Objective:The aim of this systematic review was to determine the efficacy, acceptability and tolerability of risperidone in the treatment of children and adolesce...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S151802

    authors: Maneeton N,Maneeton B,Putthisri S,Woottiluk P,Narkpongphun A,Srisurapanont M

    更新日期:2018-07-11 00:00:00

  • Influence of patient characteristics on care time in patients hospitalized with schizophrenia.

    abstract:BACKGROUND:In the current Japanese payment system for the treatment of psychiatric inpatients, the length of hospital stay and nurse staffing levels are key determinants of the amount of payment. These factors do not fully reflect the costs of care for each patient. The objective of this study was to clarify the relati...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S63009

    authors: Sugibayashi Y,Yoshimura K,Yamauchi K,Inagaki A,Ikegami N

    更新日期:2014-08-25 00:00:00

  • Drug-drug interactions involving antidepressants: focus on desvenlafaxine.

    abstract::Psychiatric and physical conditions often coexist, and there is robust evidence that associates the frequency of depression with single and multiple physical conditions. More than half of patients with depression may have at least one chronic physical condition. Therefore, antidepressants are often used in cotherapy w...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S157708

    authors: Low Y,Setia S,Lima G

    更新日期:2018-02-19 00:00:00

  • Management of refractory complex partial seizures: current state of the art.

    abstract::Diagnosis of complex partial epilepsy is based on the clinical history, and laboratory tests, including EEG and neuroimaging studies, corroborate the diagnosis. The goal of epilepsy management is to make the patient completely seizure-free without drug-induced side effects, even in the patient with refractory complex ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s4489

    authors: Treiman DM

    更新日期:2010-06-24 00:00:00

  • Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia.

    abstract::Olanzapine long-acting injection (OLAI) is a crystalline salt composed of olanzapine and pamoic acid, which permits a depot intramuscular formulation of olanzapine. The half-life of olanzapine pamoate is 30 days, and its steady state is reached approximately at 12 weeks. Oral supplementation of olanzapine is not requi...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S5463

    authors: Di Lorenzo R,Brogli A

    更新日期:2010-09-07 00:00:00

  • Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression.

    abstract::Depression is a major psychiatric disorder. The standard treatment for depression is antidepressant medication, but the responses to antidepressant treatment are only partial, even poor, among 30%-45% of patients. Refractory depression is defined as depression that does not respond to antidepressant therapy after 4 we...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S40466

    authors: Chen SJ,Chang CH,Tsai HC,Chen ST,Lin CCh

    更新日期:2013-01-01 00:00:00

  • Sensory function in cluster headache: an observational study comparing the symptomatic and asymptomatic sides.

    abstract:Background:Based on inconsistent sensory alterations demonstrated in cluster headache (CH), the aim of this study was to determine whether patients with CH develop sensory changes in the symptomatic side compared to the asymptomatic side. Methods:Quantitative sensory testing (QST), including pressure pain threshold (P...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S186051

    authors: Malo-Urriés M,Hidalgo-García C,Estébanez-de-Miguel E,Tricás-Moreno JM,Santos-Lasaosa S,Jahanshahi M

    更新日期:2018-12-10 00:00:00

  • Anxiety and depression in patients with head and neck cancer: 6-month follow-up study.

    abstract:OBJECTIVE:We aimed to assess psychiatric morbidities of patients with head and neck cancer (HNC) in a prospective study at pretreatment, and 3 and 6 months after treatment, and to compare their health-related quality of life (HRQL) between those with and without depressive disorders (depression). MATERIALS AND METHODS...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S103203

    authors: Wu YS,Lin PY,Chien CY,Fang FM,Chiu NM,Hung CF,Lee Y,Chong MY

    更新日期:2016-04-27 00:00:00

  • Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced.

    abstract::Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that often persists in adulthood. It is defined by inattention and/or hyperactivity-impulsivity. ADHD is associated with many comorbidities, including eating disorders (EDs). In the last decade, studies have reported that ADHD is linked w...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S68763

    authors: Ptacek R,Stefano GB,Weissenberger S,Akotia D,Raboch J,Papezova H,Domkarova L,Stepankova T,Goetz M

    更新日期:2016-03-03 00:00:00

  • Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE.

    abstract:BACKGROUND:PULSE was a large, observational, multicenter study designed to evaluate the efficacy and safety of agomelatine in the treatment of major depression in patients with cardiovascular disease (CVD). METHODS:Patients with mild-to-moderate major depressive episodes, without psychotic symptoms, were treated as ou...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S129793

    authors: Medvedev VE

    更新日期:2017-04-21 00:00:00

  • Management of migraine in adolescents.

    abstract::Headaches in children and adolescents are still under-diagnosed. 75% of children are affected by primary headache by the age of 15 with 28% fitting the ICHD2 criteria of migraine. Migraine is considered a chronic disorder that can severely impact a child's daily activities, including schooling and socializing. Early r...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s495

    authors: Kabbouche MA,Gilman DK

    更新日期:2008-06-01 00:00:00

  • Ropinirole for the treatment of restless legs syndrome.

    abstract::Dopaminergic agents, anticonvulsants, benzodiazepines, opiates, and iron supplementation comprise the classes of medications commonly used to treat restless legs syndrome (RLS), which is a disorder that is estimated to affect about 1 in 10 individuals worldwide and impacts an affected patient's sleep, mood, daytime fu...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/nedt.2006.2.4.407

    authors: Kushida CA

    更新日期:2006-12-01 00:00:00

  • Evaluation of BPPV with vertebral artery values.

    abstract:Objectives:The aim of this study was to investigate the association between benign paroxysmal positional vertigo (BPPV) and vertebral artery (VA) flow rates and diameters by using Doppler ultrasonography in patients with BPPV. Additionally, we aimed to investigate the abnormalities of VA values obtained by extracranial...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S169991

    authors: Yazıcı A,İnanç Y

    更新日期:2018-08-06 00:00:00

  • Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients.

    abstract:Purpose:Dual diagnosis (DD) is the co-occurrence of both a mental illness and a substance use disorder (SUD). Lots of studies have analysed the integrated clinical approach, which involves both psychiatry and toxicology medical experts. The purpose of this study is to analyse the socio-demographic characteristics and t...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S222567

    authors: Milano G,Vergani HM,Cattedra S,Carrozzino R,Mattioli F,Robbiano L,Martelli A

    更新日期:2019-12-18 00:00:00